Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment

The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which can be in the form of solid tumors and hematological malignancies. The most common hematological malignancies a...

Descripción completa

Detalles Bibliográficos
Autores principales: Satyarth, Satyam, Parikh, Sonia, Anand, Asha, Sawhney, Jyoti, Panchal, Harsha, Patel, Apurva, Shah, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686982/
https://www.ncbi.nlm.nih.gov/pubmed/29200689
http://dx.doi.org/10.4103/ijmpo.ijmpo_110_16
_version_ 1783278882436153344
author Satyarth, Satyam
Parikh, Sonia
Anand, Asha
Sawhney, Jyoti
Panchal, Harsha
Patel, Apurva
Shah, Sandeep
author_facet Satyarth, Satyam
Parikh, Sonia
Anand, Asha
Sawhney, Jyoti
Panchal, Harsha
Patel, Apurva
Shah, Sandeep
author_sort Satyarth, Satyam
collection PubMed
description The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which can be in the form of solid tumors and hematological malignancies. The most common hematological malignancies are acute myeloid leukemia/myelodysplastic syndrome. Acute lymphoblastic leukemia (ALL) is relatively uncommon in occurrence in this setting. Furthermore, the average refractory period for hematological malignancies varies from 3 to 5 years. We report a case of a young female who developed ALL while on adjuvant therapy for ES.
format Online
Article
Text
id pubmed-5686982
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56869822017-12-01 Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment Satyarth, Satyam Parikh, Sonia Anand, Asha Sawhney, Jyoti Panchal, Harsha Patel, Apurva Shah, Sandeep Indian J Med Paediatr Oncol Case Report The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which can be in the form of solid tumors and hematological malignancies. The most common hematological malignancies are acute myeloid leukemia/myelodysplastic syndrome. Acute lymphoblastic leukemia (ALL) is relatively uncommon in occurrence in this setting. Furthermore, the average refractory period for hematological malignancies varies from 3 to 5 years. We report a case of a young female who developed ALL while on adjuvant therapy for ES. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5686982/ /pubmed/29200689 http://dx.doi.org/10.4103/ijmpo.ijmpo_110_16 Text en Copyright: © 2017 Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Satyarth, Satyam
Parikh, Sonia
Anand, Asha
Sawhney, Jyoti
Panchal, Harsha
Patel, Apurva
Shah, Sandeep
Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
title Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
title_full Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
title_fullStr Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
title_full_unstemmed Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
title_short Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
title_sort acute lymphoblastic leukemia as secondary malignancy in a case of ewing's sarcoma on treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686982/
https://www.ncbi.nlm.nih.gov/pubmed/29200689
http://dx.doi.org/10.4103/ijmpo.ijmpo_110_16
work_keys_str_mv AT satyarthsatyam acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment
AT parikhsonia acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment
AT anandasha acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment
AT sawhneyjyoti acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment
AT panchalharsha acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment
AT patelapurva acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment
AT shahsandeep acutelymphoblasticleukemiaassecondarymalignancyinacaseofewingssarcomaontreatment

Ejemplares similares